Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats.
A granulated formulation of 22.2% fenbendazole was tested for anthelmintic activity against helminths in cats. The drug was administered in 20 g of canned food on each of 3 days at a dosage of 50 mg/kg of body weight/day. Of 31 young adult cats harboring naturally occurring infections of Toxocara cati, 16 were treated and 15 served as controls. There was 100% clearance of ascarids from all treated cats. Among controls, 18% of the ascarid burden was expelled naturally. Thirty additional cats were acclimated for 2 months prior to infecting them experimentally with Aelurostrongylus abstrusus, Taenia taeniaeformis, and Ancylosatoma tubaeforme. Treatment caused a transitory reduction in the number of lungworm larvae. Histopathologically, cells of developing eggs and of a majority of 1st-stage larvae in lungs of treated cats had evidence of marked degeneration and necrosis, whereas the same stage of larvae in lungs of control cats were normal. Although the number of lung lesions in treated cats was approximately half the number found in controls, there was no significant (P > 0.05) indication that this was due to treatment. Fenbendazole was effective against induced infections of A tubaeforme and Taen taeniaeformis. Greater than 99.9% of hookworms were expelled from 16 treated cats as compared with a 2% natural expulsion from 15 controls. Of 24 cats that developed patent infections of Taen taeniaeformis, 12 were treated and cleared of this parasite, whereas 9 of 12 controls continued to harbor 1 to 10 tapeworms at the time of necropsy. Fenbendazole at a dosage of 50 mg/kg/day x 3 days appeared to be an effective anthelmintic against the common ascarid, hookworm, and tapeworm of cats. Its activity against lungworms was inconclusive at the dosage used, but the data suggest the need for investigating its activity against this parasite at higher dosages, for longer periods of treatment, or both.
D000724:Ancylostomiasis / Q000188:drug therapy / Q000662:veterinary; D000818:Animals; D001562:Benzimidazoles / Q000627:therapeutic use*; D002371:Cat Diseases / Q000188:drug therapy*; D002415:Cats; D005273:Fenbendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D006374:Helminthiasis, Animal; D008681:Metastrongyloidea; D009349:Nematode Infections / Q000188:drug therapy / Q000662:veterinary; D013622:Taeniasis / Q000188:drug therapy / Q000662:veterinary; D014120:Toxocariasis / Q000188:drug therapy / Q000662:veterinary
D001562:Benzimidazoles; D005273:Fenbendazole